[{"NetIncomeLoss_1_Q3_USD":-21776000.0,"StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0_Q3_USD":18300000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":19000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":86302000.0,"Depreciation_1_Q3_USD":2400000.0,"Depreciation_3_Q3_USD":6900000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-27157000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":179000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":16000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-117000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":5497000.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0_Q3_USD":9253000.0,"CommitmentsAndContingencies_0_Q3_USD":0.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q3_USD":33238000.0,"DueFromRelatedPartiesCurrent_0_Q3_USD":100000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":108246579.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":101853047.0,"InterestPaidNet_3_Q3_USD":19000.0,"InsuranceSettlementsReceivableCurrent_0_Q3_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":2545000.0,"AssetsCurrent_0_Q3_USD":98018000.0,"Assets_0_Q3_USD":180535000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":62122000.0,"CommonStockSharesIssued_0_Q3_shares":108592583.0,"IncomeTaxesPaidNet_3_Q3_USD":6000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":-12000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-17000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":5607000.0,"DueToRelatedPartiesCurrent_0_Q3_USD":1356000.0,"FinanceLeaseInterestExpense_1_Q3_USD":9000.0,"FinanceLeaseInterestExpense_3_Q3_USD":19000.0,"AccruedSalariesCurrent_0_Q3_USD":1113000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":917000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":353000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":4128302.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":4711000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":16603000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":85581000.0,"OperatingLeaseLiability_0_Q3_USD":16601000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-12000.0,"ConstructionPayableCurrent_0_Q3_USD":164000.0,"Liabilities_0_Q3_USD":31913000.0,"Revenues_3_Q3_USD":90000.0,"CommonStockValue_0_Q3_USD":11000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_1_Q3_USD":-19000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_3_Q3_USD":-14000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_1_Q3_USD":-381000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_3_Q3_USD":-474000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":2000.0,"Revenues_1_Q3_USD":68000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":6000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":195000.0,"AccruedBonusesCurrent_0_Q3_USD":1838000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":54080000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":19152000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":17284000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":44227000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":-116000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":96000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":769000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q3_USD":0.0,"InvestmentIncomeNet_1_Q3_USD":66000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":871170000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":11250000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":27688000.0,"OtherAssetsNoncurrent_0_Q3_USD":2029000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-21793000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-60263000.0,"OtherAssetsCurrent_0_Q3_USD":90000.0,"PrepaidRent_0_Q3_USD":422000.0,"ImpairmentOfInvestments_1_Q3_USD":0.0,"ImpairmentOfInvestments_3_Q3_USD":0.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q3_USD":16000.0,"RealizedInvestmentGainsLosses_1_Q3_USD":-2000.0,"RealizedInvestmentGainsLosses_3_Q3_USD":-2000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":86734000.0,"IncreaseDecreaseInDueToRelatedPartiesCurrent_3_Q3_USD":1091000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":6864000.0,"InvestmentIncomeNet_3_Q3_USD":319000.0,"StockRepurchasedAndRetiredDuringPeriodShares_3_Q3_shares":0.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-17000.0,"UnrealizedGainLossOnInvestments_3_Q3_USD":-12000.0,"ShareBasedCompensation_3_Q3_USD":1472000.0,"LiabilitiesCurrent_0_Q3_USD":20663000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":6563000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_3_Q3_USD":6582000.0,"ProceedsFromWarrantExercises_3_Q3_USD":0.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-47397000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":711000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":1472000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":12180000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":485000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-60245000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":4000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":24834000.0,"MarketableSecuritiesGainLoss_3_Q3_USD":-2000.0,"PaymentsToAcquireEquityMethodInvestments_3_Q3_USD":0.0,"CommonStockSharesOutstanding_0_Q3_shares":108592583.0,"AssetImpairmentCharges_3_Q3_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-21774000.0,"AccountsPayableCurrent_0_Q3_USD":6160000.0,"NonoperatingIncomeExpense_3_Q3_USD":495000.0,"NonoperatingIncomeExpense_1_Q3_USD":153000.0,"NetIncomeLoss_3_Q3_USD":-60251000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":55864000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":339000.0,"PrepaidInsurance_0_Q3_USD":657000.0,"OperatingLeasePayments_1_Q3_USD":1100000.0,"OperatingLeasePayments_3_Q3_USD":3200000.0,"OtherAssetsMiscellaneousNoncurrent_0_Q3_USD":49000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":27867000.0,"StockIssued1_3_Q3_USD":1233000.0,"SecurityDeposit_0_Q3_USD":113000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.09,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3_Q3_pure":0.21,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":74000.0,"ProceedsFromStockOptionsExercised_1_Q3_USD":400000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":917000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":8977000.0,"EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_3_Q3_pure":0.0,"OtherSundryLiabilitiesCurrent_0_Q3_USD":37000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_1_Q3_USD":-321000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_3_Q3_USD":-485000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-722442000.0,"InvestmentIncomeInterest_3_Q3_USD":795000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":61353000.0,"PaymentsForRepurchaseOfCommonStock_3_Q3_USD":0.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_3_Q3_USD":1574000.0,"OperatingIncomeLoss_1_Q3_USD":-21927000.0,"OperatingIncomeLoss_3_Q3_USD":-60740000.0,"CommonStockSharesAuthorized_0_Q3_shares":500000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2291000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":1083000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":2551000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_1_Q3_USD":-2000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_3_Q3_USD":-2000.0,"InterestReceivableCurrent_0_Q3_USD":510000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":86302000.0,"DebtConversionConvertedInstrumentAmount1_3_Q3_USD":0.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":14602000.0,"InvestmentIncomeInterest_1_Q3_USD":449000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":1625000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":180535000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":711000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-425000.0,"RestrictedCashAndCashEquivalents_0_Q3_USD":179000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":62134000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":2238000.0,"StockholdersEquity_0_Q3_USD":148622000.0,"OtherLiabilitiesCurrent_0_Q3_USD":2299000.0,"ProfitLoss_3_Q3_USD":-60251000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.2,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.59,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":5164000.0,"OperatingExpenses_1_Q3_USD":21995000.0,"OperatingExpenses_3_Q3_USD":60830000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":5351000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q3_USD":0.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":80698000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_3_Q3_USD":0.0,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_1_Q3_USD":0.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":1472000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":829000.0,"Ticker":"IBRX","CIK":"1326110","name":"NANTKWEST, INC.","OfficialName":"ImmunityBio Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1985576569.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20201109"}]